| |
|
 | | tiempo | vistas | |
 | The basal ganglia - The direct pathway | 10:47 | 3,155 | es en una lista |
 | What is Parkinson's disease? | 8:54 | 7,059 | es en una lista |
 | The basal ganglia - Concepts of the indirect pathway | 8:43 | 2,425 | es en una lista |
 | The basal ganglia - Details of the indirect pathway | 8:26 | 1,619 | es en una lista |
 | Putting it all together - Pathophysiology of Parkinson's disease | 6:10 | 1,962 | es en una lista |
 | Non-movement symptoms of Parkinson's disease | 8:39 | 1,586 | es en una lista |
 | Movement signs and symptoms of Parkinson's disease | 10:26 | 2,232 | es en una lista |
 | Managing Parkinson's disease with medications | 9:59 | 1,260 | es en una lista |
 | Genetics and Parkinson's disease | 12:30 | 935 | es en una lista |
 | Managing Parkinson's disease with surgery | 9:10 | 765 | es en una lista |
 | Diagnosing Parkinson's disease | 9:42 | 1,101 | es en una lista |
 | Diabetic nephropathy - Mechanisms | 9:43 | 4,026 | |
 | What is diabetes mellitus? | 8:28 | 11,615 | |
 | Types of diabetes | 5:58 | 3,693 | |
 | Treating type II diabetes - Pharmacology | 9:17 | 3,719 | |
 | Treating type II diabetes - A practical approach | 2:23 | 1,706 | |
 | Treating type I diabetes | 8:49 | 2,310 | |
 | Pathophysiology - Type II diabetes | 7:44 | 4,530 | |
 | Diagnosing diabetes | 8:23 | 2,335 | |
 | Pathophysiology - Type I diabetes | 11:60 | 5,347 | |
 | Diabetic retinopathy | 13:21 | 3,890 | |
 | Diabetic nephropathy - Clinical presentation & treatment | 10:50 | 1,603 | |
 | Breaking down diabetes | 6:57 | 4,099 | |
 | Acute complications of diabetes - Hyperosmolar hyperglycemic nonketotic state | 10:25 | 2,885 | |
 | Acute complications of diabetes - Diabetic ketoacidosis | 11:26 | 4,417 | |
 | Multiple Sclerosis | 11:40 | 1,625 | |
 | Parkinson's Disease | 9:51 | 543 | |
 | What is primary myelofibrosis? | 7:44 | 1,627 | |
 | What is chronic myelogenous leukemia? | 9:50 | 1,558 | |
 | What is essential thrombocythemia? | 9:37 | 2,032 | |
 | What is polycythemia vera? | 10:35 | 2,956 | |
 | What are myeloproliferative disorders? | 10:15 | 2,671 | |
 | The old brain | 7:11 | 5,756 | |
 | Overview of the functions of the cerebral cortex | 5:44 | 6,527 | |
 | Hemispheric differences and hemispheric dominance | 4:37 | 4,672 | |
 | Early methods of studying the brain | 6:27 | 4,736 | |
 | Twin studies and adoption studies | 9:52 | 5,369 | |
 | Modern ways of studying the brain | 5:18 | 5,066 | |
 | Lesion studies and experimental ablation | 6:41 | 4,624 | |
 | The spotlight model of attention and our ability to multitask | 7:28 | 4,153 | es en una lista |
 | Bioenergetics: The transformation of free energy in living systems | 7:42 | 1,270 | es en una lista |
 | Why we need metabolism? | 7:42 | 1,123 | es en una lista |
 | How does the body adapt to starvation | 14:56 | 2,758 | es en una lista |
 | Insulin and glucagon | 11:43 | 10,794 | es en 2 listas |
 | Tissue specific metabolism and the metabolic states | 12:29 | 4,703 | es en 2 listas |
 | Hormones, body mass, and obesity | 4:38 | 3,720 | es en una lista |
 | Production of insulin and glucagon | 8:60 | 5,469 | es en una lista |
 | Hormone control of hunger | 3:37 | 4,219 | es en una lista |
 | Zimbardo prison study The Stanford prison experiment | 7:20 | 6,444 | |
 | What can we learn from the Milgram experiment | 4:21 | 4,490 | |
 | Milgram experiment on obedience | 7:60 | 5,272 | |
 | Factors that influence obedience and conformity | 7:45 | 5,832 | |
 | Events that inspired the Milgram studies on obedience | 4:00 | 4,352 | |
 | Conformity and obedience | 5:58 | 5,525 | |
 | Asch conformity studies (Asch line studies) | 9:56 | 5,194 | |
 | A closer look at the Stanford prison experiment | 6:55 | 4,491 | |
 | Types of animal communication | 8:58 | 3,423 | |
 | Animal communication | 4:22 | 3,503 | |
 | Three components of emotion and universal emotions | 8:30 | 4,223 | |
 | Mass media | 5:57 | 5,025 | |
 | Evolution and human culture | 5:44 | 4,285 | |
 | Substance use disorders | 7:31 | 4,869 | |
 | Epithelial and connective tissue | 7:20 | 6,667 | es en una lista |
 | Telomeres and single copy DNA vs repetitive DNA | 5:34 | 10,231 | es en una lista |
 | The nucleus | 6:50 | 7,333 | es en una lista |
 | Mitochondria | 15:11 | 9,217 | es en una lista |
 | Characteristics of eukaryotic cells | 8:55 | 7,432 | es en una lista |
 | Lysosomes and peroxisomes | 5:43 | 6,573 | es en una lista |
 | Endoplasmic reticulum and golgi apparatus | 9:41 | 7,644 | es en una lista |
 | Absolute and relative poverty | 7:30 | 6,653 | |
 | Upward and downward mobility, meritocracy | 6:36 | 7,502 | |
 | Social reproduction | 5:12 | 6,460 | |
 | Residential segregation | 6:28 | 5,568 | |
 | Social exclusion (segregation and social isolation) | 6:20 | 7,585 | |
 | Prejudice and discrimination based on race, ethnicity, power, social class, and prestige | 3:13 | 482 | |
 | Overview of social inequality | 3:57 | 10,114 | |
 | Global inequality | 6:00 | 5,401 | |
 | Health and healthcare disparities in the US | 4:10 | 5,984 | |
 | Intergenerational and intragenerational mobility social mobility | 3:32 | 6,518 | |
 | Environmental justice | 4:33 | 5,837 | |
 | Mitochondria, apoptosis, and oxidative stress | 11:32 | 3,711 | es en una lista |
 | Stem cells | 11:54 | 4,870 | es en una lista |
 | Cellular specialization (differentiation) | 8:31 | 3,724 | es en una lista |
 | Telomeres and cell senescence | 10:53 | 4,247 | es en una lista |
 | Cellular movement | 7:34 | 2,890 | es en una lista |
 | Cellular communication | 6:37 | 3,502 | es en una lista |
 | Specific heat and latent leat of fusion and vaporization | 14:57 | 6,619 | |
 | Zeroth law of thermodynamics | 6:12 | 4,392 | |
 | PV diagrams - part 2: Isothermal, isometric, adiabatic processes | 13:00 | 5,885 | |
 | PV diagrams - part 1: Work and isobaric processes | 11:54 | 4,670 | |
 | Second law of thermodynamics | 13:41 | 14,711 | |
 | First law of thermodynamics | 11:23 | 8,186 | |
 | First law of thermodynamics problem solving | 7:34 | 3,456 | |
 | Southern blot | 5:10 | 11,493 | |
 | DNA libraries & generating cDNA | 3:43 | 7,199 | |
 | Safety and ethics of DNA technologies | 4:20 | 3,859 | |
 | Restriction enzymes | 7:58 | 13,531 | |
 | Hybridization (microarray) | 8:57 | 9,057 | |
 | Polymerase chain reaction (PCR) | 4:38 | 15,286 | |
 | Gene expression and function | 3:31 | 5,804 | |
|
|
|
